Kristian Reich - Net Worth and Insider Trading
Kristian Reich Net Worth
The estimated net worth of Kristian Reich is at least $138 Million dollars as of 2024-11-05. Kristian Reich is the Chief Scientific Officer of MoonLake Immunotherapeutics and owns about 2,967,554 shares of MoonLake Immunotherapeutics (MLTX) stock worth over $138 Million. Details can be seen in Kristian Reich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kristian Reich has not made any transactions after 2024-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kristian Reich
Kristian Reich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kristian Reich owns 1 companies in total, including MoonLake Immunotherapeutics (MLTX) .
Click here to see the complete history of Kristian Reich’s form 4 insider trades.
Insider Ownership Summary of Kristian Reich
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | 2024-02-28 | Chief Scientific Officer |
Kristian Reich Latest Holdings Summary
Kristian Reich currently owns a total of 1 stock. Kristian Reich owns 2,967,554 shares of MoonLake Immunotherapeutics (MLTX) as of February 28, 2024, with a value of $138 Million.
Latest Holdings of Kristian Reich
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | 2024-02-28 | 2,967,554 | 46.59 | 138,258,341 |
Holding Weightings of Kristian Reich
Kristian Reich Form 4 Trading Tracker
According to the SEC Form 4 filings, Kristian Reich has made a total of 3 transactions in MoonLake Immunotherapeutics (MLTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in MoonLake Immunotherapeutics is the sale of 118,922 shares on February 28, 2024, which brought Kristian Reich around $7 Million.
Insider Trading History of Kristian Reich
- 1
Kristian Reich Trading Performance
Kristian Reich Ownership Network
Ownership Network List of Kristian Reich
Ownership Network Relation of Kristian Reich
Kristian Reich Owned Company Details
What does MoonLake Immunotherapeutics do?
Who are the key executives at MoonLake Immunotherapeutics?
Kristian Reich is the Chief Scientific Officer of MoonLake Immunotherapeutics. Other key executives at MoonLake Immunotherapeutics include director & 10 percent owner Biotechnology Value Fund L P , director & Chief Executive Officer Santos Da Silva Jorge , and Chief Financial Officer Matthias Bodenstedt .
MoonLake Immunotherapeutics (MLTX) Insider Trades Summary
Over the past 18 months, Kristian Reich made 3 insider transaction in MoonLake Immunotherapeutics (MLTX) with a net sale of 200,000. Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net purchase of 802,051 shares made by Bihua Chen , a net sale of 184,740 shares made by Santos Da Silva Jorge , and a net sale of 2,000,000 shares made by Biotechnology Value Fund L P .
In summary, during the past 3 months, insiders sold 2,171,000 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 2,171,000 shares. During the past 18 months, 2,655,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 802,051 shares were bought by its insiders, resulting in a net sale of 1,853,689 shares.
MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
MoonLake Immunotherapeutics Insider Transactions
Kristian Reich Mailing Address
Above is the net worth, insider trading, and ownership report for Kristian Reich. You might contact Kristian Reich via mailing address: Dorfstrasse 29, Zug V8 6300.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
